Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
90,829,513
-
Share change
-
+2,218,272
-
Total reported value
-
$1,346,164,946
-
Put/Call ratio
-
194%
-
Price per share
-
$14.82
-
Number of holders
-
172
-
Value change
-
+$33,007,846
-
Number of buys
-
76
-
Number of sells
-
90
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q3 2020
As of 30 Sep 2020,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
172 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,829,513 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, BlackRock Inc., ArrowMark Colorado Holdings LLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Clearbridge Investments, LLC, JPMORGAN CHASE & CO, and TANG CAPITAL MANAGEMENT LLC.
This page lists
174
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.